Skip to main content
2026 CRT Conference Main banner

Robert S. Rosenson, MD

Director of Metabolism and Lipids
Mount Sinai Health System
New York, New York, United States

Robert S. Rosenson, MD, is Professor of Medicine at the Icahn School of Medicine at Mount Sinai, and Director of Metabolism and Lipids for the Mount Sinai Health System in New York, New York. He was named New York Top Doc from 2015 to 2024 and USA Top Doctor in 2019. Dr Rosenson was named recipient of the Simon Dack Award for outstanding scholarship by the JACC in 2015-2020, 2021, 2022 and 2024. The International Academy of Cardiology honored him with the Jan J. Kellerman Memorial Award in 2016 for distinguished contributions in the field of cardiovascular disease prevention. In 2017, UpToDate recognized him for 20 years of Outstanding Contributions as Editor. In 2019, he was awarded the Clinician Educator Award from the National Lipid Association. Dr. Rosenson has authored over 470 peer reviewed articles including first author publications in the New England Journal of Medicine, Lancet, Nature Medicine and JAMA.

Disclosure(s): 89Bio: Grant/Research Support (Ongoing); Amgen Inc: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Arrowhead Pharmaceuticals, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); AstraZeneca Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); CRISPR Therapeutics: Consulting Fees (e.g., advisory boards) (Ongoing); Eli Lilly and Company: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Kowa Pharmaceuticals: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Lipigon Pharmaceuticals Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); Merck Pharmaceuticals: Grant/Research Support (Ongoing); NIH: Grant/Research Support (Ongoing); Novartis Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Precision BioSciences: Consulting Fees (e.g., advisory boards) (Ongoing); Regeneron Pharma: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Ultragenyx Pharmaceuticals Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); Verve Therapeutics: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Wolters Kluwer Pharma: Royalties (Ongoing)

Presentation(s):

Email Robert